Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	775.47	854.69	589.3	602.55	778.58
Short-Term Investments	90	107.1	227.37	76.79	131.01
Cash & Short-Term Investments	865.47	961.79	816.67	679.34	909.59
Cash Growth	-10.02%	17.77%	20.21%	-25.31%	24.96%
Accounts Receivable	2.54	2.55	1.94	3.72	7.63
Other Receivables	26.07	6.84	1.37	4.71	2.88
Receivables	28.61	9.39	3.3	8.43	10.51
Inventory	157.36	93.67	73.79	54.74	25.33
Other Current Assets	41.08	14.08	11.81	45.06	20.09
Total Current Assets	1,093	1,079	905.58	787.57	965.53
Property, Plant & Equipment	939.2	904.32	604.39	485.56	277.18
Long-Term Investments	-	-	10.3	17.18	7.48
Other Intangible Assets	6.4	5.06	3.84	3.84	5.18
Long-Term Deferred Tax Assets	37.71	53.39	20.76	17.32	11.82
Other Long-Term Assets	19.15	117.33	248.41	172.55	96.93
Total Assets	2,095	2,159	1,793	1,484	1,364
Accounts Payable	18.27	11.98	21.77	14.95	7.18
Current Portion of Leases	23.28	24.24	13.27	32.28	24.69
Current Income Taxes Payable	67.76	89.03	82.94	70.84	29.13
Current Unearned Revenue	73.85	202.57	60.09	122.95	111.56
Other Current Liabilities	145.75	129.62	147.93	92.93	121.95
Total Current Liabilities	328.91	457.43	326	333.95	294.51
Long-Term Leases	121.94	144.78	49.82	66.9	105.27
Long-Term Deferred Tax Liabilities	103.06	105.19	57.16	22.16	39.4
Other Long-Term Liabilities	28.23	25.59	35.02	37.43	36.09
Total Liabilities	582.13	732.99	468	460.44	475.27
Common Stock	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	25.44	25.44
Retained Earnings	973.11	892.8	771.66	460.46	323.74
Comprehensive Income & Other	-8.56	-15.04	5.33	-6.95	-4.97
Total Common Equity	1,513	1,426	1,325	1,024	888.84
Shareholders' Equity	1,513	1,426	1,325	1,024	888.84
Total Liabilities & Equity	2,095	2,159	1,793	1,484	1,364
Total Debt	145.21	169.02	63.09	99.18	129.96
Net Cash (Debt)	720.26	792.78	753.58	580.16	779.64
Net Cash Growth	-9.15%	5.20%	29.89%	-25.59%	27.61%
Net Cash Per Share	13.21	14.54	13.82	10.64	14.30
Filing Date Shares Outstanding	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.46	54.46	54.46	54.46	54.46
Working Capital	763.6	621.51	579.57	453.62	671.02
Book Value Per Share	27.78	26.18	24.33	18.79	16.32
Tangible Book Value	1,506	1,421	1,321	1,020	883.66
Tangible Book Value Per Share	27.66	26.09	24.26	18.72	16.22
Land	64.9	-	-	-	-
Buildings	517.01	487.13	482.71	-	-
Machinery	343.25	293.4	82.42	62.95	98.43
Construction In Progress	0.3	17.79	-	331.26	86.92
Leasehold Improvements	45.44	44.01	44.79	44.4	44.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.